We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Development of Leukemia and Lymphoma Traced to Loss of T-cell Differentiation Controls

By LabMedica International staff writers
Posted on 22 Dec 2016
Print article
Image: Members of the TET protein family protect against cancer. Left: Normal liver in mice with fully functional TET proteins. Right: Without TET2 and TET3, mice develop a lethal disease resembling lymphoma within weeks of birth, their livers overloaded with iNKT cells (Photo courtesy of Dr. Angeliki Tsagaratou, La Jolla Institute for Allergy and Immunology).
Image: Members of the TET protein family protect against cancer. Left: Normal liver in mice with fully functional TET proteins. Right: Without TET2 and TET3, mice develop a lethal disease resembling lymphoma within weeks of birth, their livers overloaded with iNKT cells (Photo courtesy of Dr. Angeliki Tsagaratou, La Jolla Institute for Allergy and Immunology).
Loss of TET protein tumor suppressor activity disrupts white blood cell development, which can lead to leukemia, lymphoma, and other cancers.

DNA methylation is an epigenetic mechanism that is important for controlling gene expression. TET proteins are among the factors taking part in this critical process. The proteins encoded by TET (ten-eleven translocation) family genes are demethylases that oxidize 5-methylcytosine in DNA to 5-hydroxymethylcytosine and other oxidation products.

To learn why TET proteins promote cancer development, investigators at the La Jolla Institute for Allergy and Immunology (CA, USA) genetically engineered a line of mice to lack the genes for both TET2 (TET methylcytosine dioxygenase 2) and TET3 (TET methylcytosine dioxygenase 3) in CD4+CD8+ double-positive T-cells. These mice developed a lethal disease resembling lymphoma within weeks of birth, their spleens and livers overwhelmed with invariant natural killer T-cells (iNKT cells), a normally rare kind of T-cell.

The investigators reported in the November 21, 2016, online edition of the journal Nature Immunology that TET2-TET3 double-knockout (DKO) iNKT cells displayed pronounced skewing toward the NKT17 lineage, with increased DNA methylation and impaired expression of genes encoding key lineage-specifying factors.

Transfer of purified TET2-TET3 DKO iNKT cells into immunocompetent recipient mice resulted in an uncontrolled expansion that developed into a lymphoproliferative disease as lethal as that seen in TET2/3 mutant mice.

"We knew that TET proteins were involved in human cancer but we did not know how they regulated T-cell development," said first author Dr. Angeliki Tsagaratou, a researcher at the La Jolla Institute for Allergy and Immunology. "In the new study we saw huge increases in the proliferation of the special iNKT cells in TET2/3 mutant mice. Once growth control was lost, those cells underwent the kind of malignant transformation that gives rise to T-cell lymphoma in humans. When TET proteins are lost, iNKT cells that lack them apparently become trapped in an immature, highly proliferative state. Unlike normal cells, they cannot switch off growth-promoting genes: they just keep dividing."

"Right now we do not know how TET mutations specifically contribute to either T-cell lymphomas or leukemias. But we think these mutations are early events in both," said Dr. Tsagaratou. "The search is on is to discover additional cancer-causing genes downstream of TET mutations that drive uncontrolled cell division in either context. Identification of additional factors would give us a broad idea of all steps in pathway and provide multiple targets to hit."

Related Links:
La Jolla Institute for Allergy and Immunology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.